CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Planned sale Director sold 42,461 shares at $25.09 ($1,065,206)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 10,000 shares at $25.07 ($250,650)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,343 shares at $23.64 ($126,316)
- 4 Option exercise Director acquired 1,211 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,501 shares at $19.87 ($109,325)
- 4 Planned sale Director sold 61,885 shares at an average $20.13 ($1,245,698)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 22,117 shares at an average $20.11 ($444,809)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 2,805 shares at $18.24 ($51,158)
- 4 Open-market sale Director sold 12,126 shares at $18.24 ($221,154)
- 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 1,683 shares at $18.24 ($30,695)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 10,000 shares (option exercise)
- 4 Option exercise GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 26,250 shares (option exercise)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 13,712 shares at $15.00 ($205,680)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 4,504 shares at $12.82 ($57,724)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 4,503 shares at $11.63 ($52,379)
- 4 Option exercise Director acquired 1,210 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 3,000,000 shares at $10.20 ($30,600,000)
Page 4 of 16 · 305 filings